Skip Navigation
Department of Health and Human Services www.hhs.gov
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Presentation to Slide Tray Presentation:

Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and/or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Patients With Stable Ischemic Heart Disease and Preserved Left Ventricular Systolic Function

Slide: 29 of 29

Steps in the Informed Decisionmaking Process for Adding an ACEI or an ARB to Standard Medical Therapy for Stable Ischemic Heart Disease With Preserved Left Ventricular Systolic Function

Deciding to add an angiotensin-converting enzyme inhibitor (ACEI) or and angiotensin II-receptor blocker (ARB) to your patient’s treatment regimen is a small but important part of the relationship between you and your patient who has stable ischemic heart disease with preserved left ventricular systolic function.